Literature DB >> 10665546

Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists.

C Heeschen1, C W Hamm.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10665546     DOI： 10.1016/S0140-6736(99)00464-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.

Authors:  D P Chew; D L Bhatt
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 2.  [Review of plasma anti-aggregants and their indications in primary care. Eight years later].

Authors:  M Blasco Valle; J F Lucía Cuesta
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

3.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

4.  PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE.

Authors:  Roy R Hantgan; Martin Guthold; Samrat Dutta; David A Horita
Journal:  Nano Life       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.